Lateral neck metastasis is an independent risk factor of the loco-regional recurrence in papillary thyroid carcinoma (PTC). Ultrasonography (US) and computed tomography are frequently performed to diagnose the lymph node (LN) metastasis. However, some metastatic LNs can remain after initial treatment and can present as regional recurrences. A 19-year-old woman was diagnosed as having 1.99 cm PTC. No abnormal LNs was detected on preoperative CT and US. She underwent operation and radioactive iodine (RAI) therapy: seven months after RAI therapy, thyroglobulin level was elevated. However, no metastatic LNs were detected on neck CT, US and positron emission tomography-CT. Neck exploration was performed and metastatic PTC was diagnosed in bilateral level III and IV. A radiologist retrospectively reviewed the neck CTs taken before the first surgery and the second surgery. There was no significant difference in the LN appearances of two CTs. On both CT scans, all LNs were very small, homogenously enhanced, without calcification or cystic changes. Korean J Otorhinolaryngol-Head Neck Surg 2018;61(6):312-6 Key WordsZZAdjuvant radiotherapy ㆍNeck dissections ㆍPapillary thyroid carcinoma.
Introduction
Lymph node (LN) metastasis develops in approximately 20% to 90% of patients with papillary thyroid carcinoma (PTC). 1) Prophylactic central neck dissection (CND) is frequently performed according to primary tumor stage. However, lateral neck dissection (LND) is not recommended in clinically N0 PTC. However, the incidence of lateral neck metastasis has been reported as 18% to 64% and the incidence of occult lateral neck metastasis, which is not diagnosed by preoperative physical examination and radiologic tests was reported up to 18%. [2] [3] [4] Lateral neck metastasis is known as an independent risk factor of the loco-regional recurrence, especially in patients older than 45 years.
5-7)
Ultrasonography (US) is a primary imaging modality for preoperative evaluation of LN metastases. Computed tomography (CT) is also frequently performed in many institutions, considering the operator dependency of US. However, the diagnostic sensitivity of radiologic neck evaluation does not exceed 80%. [8] [9] [10] [11] We present a case of recurrent PTC in lateral neck after initial surgery and postoperative adjuvant RAI treatment. To investigate whether the metastatic LNs were true recurrence or remnant disease undiagnosed before initial surgery, we analyzed and compared the radiologic findings of CT scans before initial surgery and those before revision surgery.
Case
A 19-year-old woman who had been followed up in pediatric department for glycogen storage disease, was referred Fig. 1 . US images before initial surgery and before revision surgery. US images of thyroid mass before initial surgery. Papillary carcinoma was found in right lobe of thyroid (arrow) (A). US images of neck LNs before initial surgery. This figure shows very small, homogenously enhanced LN (level III) (black arrow). There was no calcification or cystic change. SCM muscle was seen (white arrow) (B). US images of neck LNs before revision surgery. There were no metastatic LNs at level IV (white arrowhead). Internal jugular vein (black arrow), carotid artery (black arrowhead), and SCM muscle (white arrow) were seen (C). US: ultrasonography, LN: lymph node, SCM: sternocleidomastoid.
to the department of otolaryngology with a thyroid mass accidentally detected in neck CT. US with fine needle aspiration biopsy was performed. The size of the thyroid mass was 1.99 cm and the aspiration cytology was consistent with PTC. There was no abnormal LN suspicious for metastasis in CT or US ( Figs. 1 and 2 ). During surgery, gross extrathyroidal extension (ETE) was detected and CND was performed along with total thyroidectomy. Pathologically, multifocal PTCs, with the largest one 1.7 cm extended to perithyroidal soft tissue, and metastasis to 12 of 17 level VI LNs were diagnosed (pT3N1aMx). RAI therapy with 100 mCi 131I was performed 2 months after surgery. Just before RAI therapy, off-Tg level was 8.6 ng/mL with thyroid-stimulating hormone (TSH) 100.0 μIU/mL. After RAI therapy, whole body scan (WBS) showed no radioiodine uptake in previous thyroid portion nor extrathyroidal uptake. Three months after the RAI therapy, on-Tg level was 5.3 ng/mL. However, no abnormal mass was detected on thyroid bed and neck areas with US.
Seven months after RAI therapy, on-Tg level was 18.1 ng/ mL. At that moment, the patient had severe diarrhea, abdominal pain and chest discomfort. Abdominal CT and chest CT showed 1cm-sized nodule in left lower lung and a lobulated mass in anterior mediastinum and central neck. Although the lobulated mass was reported as "recurrent PTC" by a radiologist, it rather seemed like a hypertrophic thymus. There was no additional neck mass reported in neck CT, US suggesting metastatic PTC. However, because there was a high Tg level and multiple central LN metastasis (12/17) was diagnosed in the first operation, we assumed that there the possibility of subclinical lateral LN metastasis was high and performed neck exploration along with left lower lobectomy of lung (by thoracic surgeons). During neck exploration, metastatic PTCs were detected in bilateral level III, IV on frozen biopsy. With the frozen biopsy reports, we performed bilateral LND (bilateral level II, III, IV, and V dissection). Lobulated mass in central neck was cervical thymus. There was no metastatic PTC in central neck. Metastatic PTC was pathologically reported in 6 of 62 LNs (1 in left level III, 1 in left level IV, 2 in right level III, 2 in right level IV). RAI therapy with 150 mCi 131 I was performed 2 months after surgery. Just before RAI therapy, off-Tg level was 6.1 ng/mL with TSH 81.0 μIU/ mL. After RAI therapy, WBS showed no radioiodine uptake in previous thyroid portion nor extrathyroidal uptake. Two months after the RAI therapy, on-Tg level was 0.2 ng/mL. Five months after the RAI therapy, no recurrent mass was detected by US.
A radiologist retrospectively reviewed the neck CT images taken before the first surgery and before the second surgery (Fig. 2) . There was no significant difference in the LN appearances of two CTs. Especially, the LN characteristics of the levels with pathologically proven metastatic PTC were analyzed; right level III, right level IV, left level III, and left level IV. In those neck areas of both CT scans, all LNs were very small (7 11 mm in maximum axial diameter), homogenously enhanced. There were no calcification or cystic change. According to the preexisting criteria, those LNs are considered as benign or reactive lymphadenopathy.
Discussion
US is the current choice of imaging modality for preoperative evaluation of cervical LN metastases in thyroid cancer. High-resolution sonography improved the characterization of cervical LNs. Several sonographic criteria, such as loss of fatty hilum, hyperechogenecity, round shape, calcification and cystic change, have been used to detect the metastatic LNs.
12)
The sensitivity of the neck US for cervical LN metastasis has been reported variable, approximately from 40 up to 60%. 8, 13, 14) A meta-analysis study showed that the pooled patient based sensitivity for US was 72% and the pooled level-based sensitivity was lower 63%. 10) Despite high resolution and easy accessibility, operator dependency and subjectivity of US make many surgeons order CT scans before surgery. CT has been proven to be an accurate imaging modality for the detection of LN metastasis from head and neck squamous cell carcinoma. Similarly, some CT criteria can be used to predict the LN metastasis of PTC: for example, strong enhancement without hilar vessel enhancement, heterogeneous enhancement, calcification, or cystic or necrotic change. 15) However, the diagnostic criteria have not been clearly defined yet. Thus, the diagnostic accuracy of CT to predict the LN metastasis of PTC is not conclusive. In the previous studies, patient-based the sensitivity of CT scans was variable, from 57% to 100%. 8, 13) The level-based sensitivity was from 34% to 77% for all levels and from 42% to 78% for lateral neck levels. 8, 13, 14) However, the true sensitivity of CT scan is unknown yet. It is because if there is no suspected LN metastasis by radiologic evaluation, neck dissection is mostly not performed. i.e. Previous studies on diagnostic accuracy of CT included only cases for which LN metastasis was suspected and thus neck dissection was performed. The gold standard to determine the sensitivity of radiologic tests is the pathology. Therefore, missed LN metastasis by radiologic test could have affected the reported sensitivity.
Similarly, the CT criteria for diagnosis of LN metastasis may be incorrect or insufficient. Missed LN metastasis, which was not suspected by radiologic tests, has not been included to previous studies to define the CT criteria of LN metastasis. The study by Som, et al., 15) frequently cited regarding to the CT and MR criteria of LN metastasis, included only the cases in which, LN metastasis was suspected by CT or MRI and neck dissection was performed. Missed cases can give us a lot of information. Like in our case, the metastatic LN of PTC can have variable characters, against our expectations. We suggest that the diagnostic criteria of the radiologic studies for the LN metastasis of PTC be revised. In addition, considering the risk factors of subclinical lateral neck metastasis, such as age, sex, tumor size, ETE and central LN metastasis, frozen biopsy of the lateral neck LN might be performed during the operation.
